Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hooper

Showing results (391-400 of 470) with videos related to

Pageof 47
Sort By:
Thrombosis and Haemostasis|March 8, 2003
Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesisRonald T Aimes, Andries Zijlstra, John D Hooper, et al.
Epilepsia|January 1, 1996
Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidationW D Hooper, M E Franklin, P Glue, et al.
American Journal of Cancer Research|December 9, 2017
Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteasesJanet C Reid, Admire Matsika, Claire M Davies, et al.
The Journal of Biological Chemistry|June 17, 2010
Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdeltaYaowu He, Andreas Wortmann, Les J Burke, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent Small Agonists of Protease Activated Receptor 2Mei-Kwan Yau, Jacky Y Suen, Weijun Xu, et al.
British Medical Journal|June 3, 1978
Migraine in childhoodM Salmon, K Dalton, M Sweeney, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 20, 2022
CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitorsXue Lu, Yaowu He, Rebecca L Johnston, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 11, 2017
Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimensYang Chen, Brittney S Harrington, Kevin C N Lau, et al.
Histopathology|June 27, 2023
Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancerMadeline Gough, Cheng Liu, Bhuvana Srinivasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2022
Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinomaPrahlad V Raninga, Yaowu He, Keshava K Datta, et al.
Pageof 47

Showing results (391-400 of 470) with videos related to

Sort By:
Pageof 47
Thrombosis and Haemostasis|March 8, 2003
Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesisRonald T Aimes, Andries Zijlstra, John D Hooper, et al.
Epilepsia|January 1, 1996
Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidationW D Hooper, M E Franklin, P Glue, et al.
American Journal of Cancer Research|December 9, 2017
Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteasesJanet C Reid, Admire Matsika, Claire M Davies, et al.
The Journal of Biological Chemistry|June 17, 2010
Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdeltaYaowu He, Andreas Wortmann, Les J Burke, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent Small Agonists of Protease Activated Receptor 2Mei-Kwan Yau, Jacky Y Suen, Weijun Xu, et al.
British Medical Journal|June 3, 1978
Migraine in childhoodM Salmon, K Dalton, M Sweeney, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 20, 2022
CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitorsXue Lu, Yaowu He, Rebecca L Johnston, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 11, 2017
Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimensYang Chen, Brittney S Harrington, Kevin C N Lau, et al.
Histopathology|June 27, 2023
Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancerMadeline Gough, Cheng Liu, Bhuvana Srinivasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2022
Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinomaPrahlad V Raninga, Yaowu He, Keshava K Datta, et al.
Pageof 47